380P Assessing interstitial lung disease (ILD) risk in metastatic breast cancer (MBC): A comprehensive meta and network analysis of antibody-drug conjugates (ADCs) compared to available treatment options beyond first-line (1L). - Cucciniello, L.; Giudici, F.; Di Nardo, P.; Dri, A.; Della Rossa, S.; Zottarelli, E.; Noto, C.; Foffano, L.; Pastò, B.; Bolzonello, S.; Da Ros, L.; Cudia, G.; et al. (Annals of Oncology, 2024)